Bionano Genomics, Inc. (BNGO) Q4 2021 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bionano Genomics, Inc..

Watch the replay

Replay transcript excerpt

[Speaker identities could not be resolved; generic labels used] [00:00] Speaker 1: Good day and welcome to the BioNano [00:02] Speaker 1: Genomics 4th 0.25 and full year 2021 [00:05] Speaker 1: earnings conference call. Today's conference is being recorded. [00:10] Speaker 1: At this time, I would like to turn the conference over to Amy Conrad from Investor Relations. [00:15] Speaker 1: Please go ahead. [00:17] Speaker 2: Thank you, Gigi, and good afternoon, everyone. [00:20] Speaker 2: Welcome to the BioNano Genomics [00:22] Speaker 2: 4th 0.25 and full year 2021 [00:24] Speaker 2: financial results conference call. [00:26] Speaker 2: Leading the call today is Dr. Eric Holmland, CEO of BioNano. [00:31] Speaker 2: He is joined by Chris Stewart, CFO of BioNano, [00:34] Speaker 2: and Rich Shippey, [00:35] Speaker 2: CBO and head of global sales of BioNano. [00:39] Speaker 2: After market close today, BioNano issued a press release announcing its financial results for the 4th 0.25 and full year 2021. [00:46] Speaker 2: A copy of the release can be found on the investor relations page of the company's website. [00:51] Speaker 2: I would like to remind everyone that certain statements made during this conference call are forward-looking, [00:56] Speaker 2: including statements about bio-nanostrategic [00:58] Speaker 2: and commercialization [00:59] Speaker 2: plans, [01:00] Speaker 2: sales pipelines, [01:02] Speaker 2: anticipated benefits or improvements to the SAFIRE system, [01:05] Speaker 2: goals and anticipated milestones for 2022, [01:08] Speaker 2: the advantages of the SAFIRE system over current technologies, [01:12] Speaker 2: the [01:13] Speaker 2: anticipated benefits of recent acquisitions, [01:15] Speaker 2: expectations regarding timing and content of stu...